Bladder Cancer Virtual Special Issue

被引：0

作者：

Jena, R. ^{[1
]}

机构：

[1] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge, England

来源：

CLINICAL ONCOLOGY | 2018年 / 30卷 / 09期

关键词：

CARE EXCELLENCE NICE; UROTHELIAL CARCINOMA; NATIONAL INSTITUTE; RADIOTHERAPY; HEALTH;

D O I：

10.1016/j.clon.2018.05.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：525 / 526

页数：2

共 10 条

[1] Organ Preservation - Will Data Translate into Reality for Bladder Cancer Patients? [J].

Chen, R. C. .

CLINICAL ONCOLOGY, 2015, 27 (03) :133-135

[2] The Role of PD-1 Positivity in the Tumour Nest on Clinical Outcome in Upper Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy [J].

Hayakawa, N. ;

Kikuchi, E. ;

Mikami, S. ;

Fukumoto, K. ;

Oya, M. .

CLINICAL ONCOLOGY, 2018, 30 (01) :E1-E8

[3] A New Dawn for Bladder Cancer? Recommendations from the National Institute for Health and Care Excellence (NICE) on Managing Bladder Cancer [J].

Huddart, R. A. ;

Jones, R. ;

Choudhury, A. .

CLINICAL ONCOLOGY, 2015, 27 (07) :380-381

[4] Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer [J].

Leibowitz-Amit, R. ;

Israel, A. ;

Gal, M. ;

Atenafu, E. A. ;

Symon, Z. ;

Portnoy, O. ;

Laufer, M. ;

Dotan, Z. ;

Ramon, J. ;

Avni, D. ;

Fridman, E. ;

Berger, R. .

CLINICAL ONCOLOGY, 2016, 28 (12) :790-796

[5] Defining Bowel Dose Volume Constraints for Bladder Radiotherapy Treatment Planning [J].

McDonald, F. ;

Waters, R. ;

Gulliford, S. ;

Hall, E. ;

James, N. ;

Huddart, R. A. .

CLINICAL ONCOLOGY, 2015, 27 (01) :22-29

[6] Patterns of Referral to Radiation Oncology among Patients with Bladder Cancer: a Population-based Study [J].

Quirt, J. S. ;

Siemens, D. R. ;

Zaza, K. ;

Mackillop, W. J. ;

Booth, C. M. .

CLINICAL ONCOLOGY, 2017, 29 (03) :171-179

[7] Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial [J].

Sharma, Padmanee ;

Retz, Margitta ;

Siefker-Radtke, Arlene ;

Baron, Ari ;

Necchi, Andrea ;

Bedke, Jens ;

Plimack, Elizabeth R. ;

Vaena, Daniel ;

Grimm, Marc-Oliver ;

Bracarda, Sergio ;

Arranz, Jose Angel ;

Pal, Sumanta ;

Ohyama, Chikara ;

Saci, Abdel ;

Qu, Xiaotao ;

Lambert, Alexandre ;

Krishnan, Suba ;

Azrilevich, Alex ;

Galsky, Matthew D. .

LANCET ONCOLOGY, 2017, 18 (03) :312-322

[8] Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer [J].

Solanki, A. A. ;

Martin, B. ;

Korpics, M. ;

Small, C. ;

Harkenrider, M. M. ;

Mitin, T. .

CLINICAL ONCOLOGY, 2017, 29 (07) :429-435

[9] The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction? [J].

Trainor, S. ;

Choudhury, A. ;

Huddart, R. ;

Kiltie, A. E. ;

Kockelbergh, R. ;

Turner, W. ;

Birtle, A. ;

Crabb, S. J. .

CLINICAL ONCOLOGY, 2017, 29 (06) :344-347

[10] Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers [J].

Walker, M. ;

Doiron, R. C. ;

French, S. D. ;

Feldman-Stewart, D. ;

Siemens, D. R. ;

Mackillop, W. J. ;

Booth, C. M. .

CLINICAL ONCOLOGY, 2017, 29 (12) :818-826

← 1 →